339 related articles for article (PubMed ID: 23467510)
1. Use of thiopurines in inflammatory bowel disease.
Frei P; Biedermann L; Nielsen OH; Rogler G
World J Gastroenterol; 2013 Feb; 19(7):1040-8. PubMed ID: 23467510
[TBL] [Abstract][Full Text] [Related]
2. On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance.
Van Asseldonk DP; de Boer NK; Peters GJ; Veldkamp AI; Mulder CJ; Van Bodegraven AA
Curr Drug Metab; 2009 Nov; 10(9):981-97. PubMed ID: 20214590
[TBL] [Abstract][Full Text] [Related]
3. Thiopurine therapy in inflammatory bowel disease.
Ha C; Dassopoulos T
Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):575-88. PubMed ID: 20932143
[TBL] [Abstract][Full Text] [Related]
4. Evolving Considerations for Thiopurine Therapy for Inflammatory Bowel Diseases-A Clinical Practice Update: Commentary.
Hanauer SB; Sandborn WJ; Lichtenstein GR
Gastroenterology; 2019 Jan; 156(1):36-42. PubMed ID: 30195449
[TBL] [Abstract][Full Text] [Related]
5. The role of thiopurine metabolites in inflammatory bowel disease and rheumatological disorders.
Friedman AB; Sparrow MP; Gibson PR
Int J Rheum Dis; 2014 Feb; 17(2):132-41. PubMed ID: 24618304
[TBL] [Abstract][Full Text] [Related]
6. Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.
Gómez-García M; Cabello-Tapia MJ; Sánchez-Capilla AD; De Teresa-Galván J; Redondo-Cerezo E
World J Gastroenterol; 2013 Aug; 19(30):4877-86. PubMed ID: 23946592
[TBL] [Abstract][Full Text] [Related]
7. Uphill battle: Innovation of thiopurine therapy in global inflammatory bowel disease care.
Bayoumy AB; Mulder CJJ; Ansari AR; Barclay ML; Florin T; Kiszka-Kanowitz M; Derijks L; Sharma V; de Boer NKH
Indian J Gastroenterol; 2024 Feb; 43(1):36-47. PubMed ID: 38383877
[TBL] [Abstract][Full Text] [Related]
8. Thiopurines in inflammatory bowel disease revisited.
Bär F; Sina C; Fellermann K
World J Gastroenterol; 2013 Mar; 19(11):1699-706. PubMed ID: 23555158
[TBL] [Abstract][Full Text] [Related]
9. Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease--proceedings of the first Thiopurine Task Force meeting.
van Asseldonk DP; Sanderson J; de Boer NK; Sparrow MP; Lémann M; Ansari A; Almer SH; Florin TH; Gearry RB; Mulder CJ; Mantzaris G; van Bodegraven AA;
Dig Liver Dis; 2011 Apr; 43(4):270-6. PubMed ID: 20934926
[TBL] [Abstract][Full Text] [Related]
10. Review article: thiopurines in inflammatory bowel disease.
Derijks LJ; Gilissen LP; Hooymans PM; Hommes DW
Aliment Pharmacol Ther; 2006 Sep; 24(5):715-29. PubMed ID: 16918876
[TBL] [Abstract][Full Text] [Related]
11. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of mean corpuscular volume as a surrogate marker for monitoring thiopurine treatment in inflammatory bowel disease.
Dujardin RW; Meijer B; de Boer NK; D'Haens GR; Löwenberg M
Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):991-6. PubMed ID: 27257870
[TBL] [Abstract][Full Text] [Related]
13. Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives.
de Boer NKH; Peyrin-Biroulet L; Jharap B; Sanderson JD; Meijer B; Atreya I; Barclay ML; Colombel JF; Lopez A; Beaugerie L; Marinaki AM; van Bodegraven AA; Neurath MF
J Crohns Colitis; 2018 Apr; 12(5):610-620. PubMed ID: 29293971
[TBL] [Abstract][Full Text] [Related]
14. Update on the Use of Thiopurines and Methotrexate in Inflammatory Bowel Disease.
Johnson CM; Dassopoulos T
Curr Gastroenterol Rep; 2018 Sep; 20(11):53. PubMed ID: 30267281
[TBL] [Abstract][Full Text] [Related]
15. [Conservative therapy of inflammatory bowel diseases].
Nagy F
Orv Hetil; 2002 Dec; 143(50):2763-8. PubMed ID: 12583315
[TBL] [Abstract][Full Text] [Related]
16. Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines.
Dotan I; Werner L; Vigodman S; Agarwal S; Pfeffer J; Horowitz N; Malter L; Abreu M; Ullman T; Guzner-Gur H; Halpern Z; Mayer L
Inflamm Bowel Dis; 2012 Feb; 18(2):261-8. PubMed ID: 21438101
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial: Combination allopurinol-thiopurine versus standard thiopurine in patients with IBD escalating to immunomodulators (the DECIDER study).
Vasudevan A; Con D; De Cruz P; Sparrow MP; Friedman AB; Garg M; Kashkooli S; Gibson PR; van Langenberg DR
Aliment Pharmacol Ther; 2024 Feb; 59(4):504-514. PubMed ID: 38095246
[TBL] [Abstract][Full Text] [Related]
18. Outcome of concomitant treatment with thiopurines and allopurinol in patients with inflammatory bowel disease: A nationwide Danish cohort study.
Thomsen SB; Allin KH; Burisch J; Jensen CB; Hansen S; Gluud LL; Theede K; Kiszka-Kanowitz M; Nielsen AM; Jess T
United European Gastroenterol J; 2020 Feb; 8(1):68-76. PubMed ID: 32213059
[TBL] [Abstract][Full Text] [Related]
19. Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.
Holmstrøm RB; Mogensen DV; Brynskov J; Ainsworth MA; Nersting J; Schmiegelow K; Steenholdt C
Dig Dis Sci; 2018 Jun; 63(6):1583-1591. PubMed ID: 29564674
[TBL] [Abstract][Full Text] [Related]
20. The drug-survival of low-dose thioguanine in patients with inflammatory bowel disease: a retrospective observational study.
Gensmyr-Singer H; Werner M; Karling P
Therap Adv Gastroenterol; 2024; 17():17562848241228064. PubMed ID: 38384282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]